| Date Filed | Type | Description |
| 01/10/2023 |
4
| Fisher Douglas Carl (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.62, valued at
$18.6k
|
|
| 01/13/2022 |
4
| Fisher Douglas Carl (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.54, valued at
$61.6k
|
|
| 10/12/2021 |
4
| Fisher Douglas (President) has filed a Form 4 on PHOENIX BIOTECH ACQUISITION CORP.|
Txns:
| Acquired 10,000 shares
@ $0
Acquired 100,000 options to buy
@ $0
Acquired 5,000 warrants
@ $11.5, valued at
$57.5k
|
|
| 10/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| Fisher Douglas (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 27,250 options
@ $0
Granted 27,250 options to buy
@ $0.77, valued at
$21k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2020 |
4
| Fisher Douglas (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 7,500 options to buy
@ $2.14, valued at
$16.1k
|
|
| 07/25/2019 |
4
| Fisher Douglas (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 78,125 shares
@ $0 |
|
| 03/20/2019 |
4
| Fisher Douglas (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.15, valued at
$11.3k
|
|
| 06/14/2018 |
4
| Fisher Douglas (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 81,774 options to buy
@ $2.36, valued at
$193k
|
|
| 02/21/2018 |
4
| Fisher Douglas (Director) has filed a Form 4 on Precipio, Inc.|
Txns:
| Granted 31,025 options to buy
@ $0.71, valued at
$22k
Granted 77,563 options to buy
@ $0.71, valued at
$55.1k
|
|
| 09/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Fisher Douglas (Director) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Granted 46,500 options to buy
@ $8.74, valued at
$406.4k
|
|
| 10/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |